A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)

Clinical trial NCT00248183 · COMPLETED

Trial details

NCT number: NCT00248183
Sponsor: Epix Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anxiety Disorders

Start date: 2005-08-01
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.